Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lundgren

Showing results (341-350 of 681) with videos related to

Pageof 69
Sort By:
AIDS (London, England)|May 24, 2013
CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral useAmanda Mocroft, Andrew N Phillips, Jose Gatell, et al.
AIDS (London, England)|July 2, 2014
Deteriorating renal function and clinical outcomes in HIV-positive personsAmanda Mocroft, Lene Ryom, Josip Begovac, et al.
AIDS (London, England)|July 12, 2012
Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patientsLars Peters, Daniel Grint, Jens D Lundgren, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 11, 2009
Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppressionLars Peters, Amanda Mocroft, Vincent Soriano, et al.
Neuropeptides|April 1, 1992
The effects of neuropeptides on mucous glycoprotein secretion from human nasal mucosa in vitroJ Mullol, R D Rieves, J N Baraniuk, et al.
AIDS (London, England)|April 2, 2005
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohortDeborah Konopnicki, Amanda Mocroft, S de Wit, et al.
Lancet (London, England)|July 31, 2007
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort studyA Mocroft, A N Phillips, J Gatell, et al.
AIDS (London, England)|November 5, 2008
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?Joanne Reekie, Amanda Mocroft, Helen Sambatakou, et al.
BMJ (Clinical Research Ed.)|April 23, 1994
Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study GroupJ D Lundgren, C Pedersen, N Clumeck, et al.
Antiviral Therapy|November 30, 2005
Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?Amanda Mocroft, Jurgen Rockstroh, Vincent Soriano, et al.
Pageof 69

Showing results (341-350 of 681) with videos related to

Sort By:
Pageof 69
AIDS (London, England)|May 24, 2013
CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral useAmanda Mocroft, Andrew N Phillips, Jose Gatell, et al.
AIDS (London, England)|July 2, 2014
Deteriorating renal function and clinical outcomes in HIV-positive personsAmanda Mocroft, Lene Ryom, Josip Begovac, et al.
AIDS (London, England)|July 12, 2012
Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patientsLars Peters, Daniel Grint, Jens D Lundgren, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 11, 2009
Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppressionLars Peters, Amanda Mocroft, Vincent Soriano, et al.
Neuropeptides|April 1, 1992
The effects of neuropeptides on mucous glycoprotein secretion from human nasal mucosa in vitroJ Mullol, R D Rieves, J N Baraniuk, et al.
AIDS (London, England)|April 2, 2005
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohortDeborah Konopnicki, Amanda Mocroft, S de Wit, et al.
Lancet (London, England)|July 31, 2007
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort studyA Mocroft, A N Phillips, J Gatell, et al.
AIDS (London, England)|November 5, 2008
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?Joanne Reekie, Amanda Mocroft, Helen Sambatakou, et al.
BMJ (Clinical Research Ed.)|April 23, 1994
Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study GroupJ D Lundgren, C Pedersen, N Clumeck, et al.
Antiviral Therapy|November 30, 2005
Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?Amanda Mocroft, Jurgen Rockstroh, Vincent Soriano, et al.
Pageof 69